Anika Therapeutics
ANIK
#8662
Rank
NZ$0.45 B
Marketcap
NZ$34.32
Share price
-1.54%
Change (1 day)
113.68%
Change (1 year)
Categories

EPS for Anika Therapeutics (ANIK)

EPS in 2026 (TTM): NZ-$0.44

According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.46. In 2025 the company made an earnings per share (EPS) of NZ-$1.36 an increase over its 2024 EPS that were of NZ-$6.87.

EPS history for Anika Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.44-67.28%
2025NZ-$1.36-80.26%
2024NZ-$6.87-31.86%
2023NZ-$10.08448.54%
2022NZ-$1.84-455.17%
2021NZ$0.52-115.68%
2020NZ-$3.30-195.85%
2019NZ$3.4448.46%
2018NZ$2.32-40.37%
2017NZ$3.89-1.8%
2016NZ$3.967.77%
2015NZ$3.68-21.37%
2014NZ$4.6874.67%
2013NZ$2.6870.45%
2012NZ$1.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.59-3,459.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$7.28-1,669.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
NZ$17.37-3,842.31%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
NZ$0.12-126.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$6.28-1,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA